🏠︎ | Past Presentations | Advanced Practitioner | Integrative Oncology and Nutrigenomics Insights

• Event: IPM Congress 2024

• Date: 8th June 2024

• By: Dr. Wafaa Abdel-Hadi

• Estimated Read Time: 7–8 minutes

At the forefront of integrative oncology, Dr. Wafaa Abdel-Hadi delivered a captivating presentation at the IPM Congress 2024 titled "Exploring the Tumour Immune Microenvironment." Her session provided a deep dive into the intricate interplay between cancer cells and their surrounding environment, focusing on personalised strategies to enhance treatment outcomes. Through a blend of clinical expertise, patient stories, and cutting-edge research, Dr. Abdel-Hadi highlighted the importance of transforming the tumour microenvironment (TME) into an ally in the fight against cancer.

Introduction to the Tumour Microenvironment (TME)

The TME is a dynamic ecosystem comprising cancer cells, immune cells, blood vessels, stromal cells, signalling molecules, and metabolites. It is both a facilitator of cancer progression and a barrier to effective treatment. Dr. Abdel-Hadi underscored its dual nature as a challenge and an opportunity in oncology, stating:

"The tumour microenvironment is not just a passive bystander; it actively drives cancer's growth, metastasis, and resistance to treatment. By addressing its complexities, we can revolutionise patient care."

Key features of the TME include:

• Hypoxia: Low oxygen levels that promote angiogenesis and metastasis.
• Acidity: Accumulated lactate creates an immunosuppressive, acidic environment.
• Immune Evasion: Cancer cells suppress the immune response via immune checkpoint inhibitors.
• Inflammation: Chronic, unresolved inflammation fosters tumour growth.

Case Study: Triple-Negative Breast Cancer

Dr. Abdel-Hadi shared the remarkable story of a 40-year-old patient diagnosed with triple-negative breast cancer (TNBC). This aggressive cancer subtype lacks hormone receptors and HER2, leaving chemotherapy as the primary treatment. The patient, seeking alternatives to high-dose chemotherapy, consulted Dr. Abdel-Hadi after undergoing a lumpectomy.

Personalised Care Approach:

• Diagnostic Precision
  The patient underwent comprehensive tests, including:

  • Tumour markers
  • Nutrigenomic testing to identify genetic vulnerabilities
  • Basic labs (CBC, liver function tests, inflammatory markers)

• Innovative Therapies in Germany
  Dr. Abdel-Hadi referred the patient to a specialised clinic where she received:

  • Intravenous nutraceuticals tailored to her genetic profile
  • Hyperthermia therapy to stimulate her immune response
  • Low-dose chemotherapy (cyclophosphamide) instead of standard anthracyclines

• Outcome
  Three years post-treatment, the patient remains cancer-free without requiring additional chemotherapy or radiation. This case exemplifies how integrative oncology blends conventional and alternative treatments to yield positive outcomes.

Hallmarks of Cancer and Genetic Influences

Dr. Abdel-Hadi provided a comprehensive overview of cancer's hallmarks, explaining how the disease is driven by both genetic mutations and metabolic dysfunction. Key insights included:

• Proto-Oncogenes and Oncogenes
  Normal genes involved in cell growth, like KRAS and EGFR, can mutate into oncogenes, driving uncontrolled proliferation.

• Tumour Suppressor Genes
  Genes such as TP53 (p53) and BRCA act as the 'guardians' of the genome. Mutations here prevent cells from undergoing apoptosis, allowing tumours to thrive.

• Telomeres and Telomerase
  Cancer cells exploit telomerase to maintain telomere length, granting them immortality. Dr. Abdel-Hadi emphasised how targeting telomerase could disrupt this survival mechanism.

Additionally, nutrigenomics emerged as a critical tool in identifying genetic predispositions and designing tailored interventions. For instance, nutrigenomic testing can uncover mutations in TP53, informing strategies to reduce cancer risk through dietary and environmental modifications.

Transforming the TME into an Ally

Dr. Abdel-Hadi's session focused on strategies to optimise the TME, turning it from a cancer-friendly environment into one conducive to healing. These strategies included:

1. Addressing Inflammation

Chronic inflammation is a hallmark of cancer. By targeting inflammatory pathways, such as COX-2 and NF-kB, practitioners can reduce tumour growth and metastasis. Nutritional interventions and anti-inflammatory nutraceuticals like curcumin and quercetin play a pivotal role.

2. Restoring Immune Function

Cancer evades the immune system by exploiting immune checkpoints such as PD-1/PD-L1. Dr. Abdel-Hadi highlighted the importance of:

3. Modulating Metabolism

Cancer cells thrive on metabolic dysfunction, relying on glycolysis and lactate production. Nutritional strategies, such as intermittent fasting and ketogenic diets, can disrupt these pathways while supporting immune cell function. Dr. Abdel-Hadi advocated for tailoring these interventions based on each patient's unique needs.

4. Gut Microbiome Optimisation

The gut microbiome plays a central role in regulating immune responses. Dr. Abdel-Hadi shared findings on how specific microbiota strains, such as Akkermansia, can enhance the efficacy of immunotherapies. She also cautioned against imbalances, such as co-occurrence with Clostridium difficile, which can negate positive effects.

Targeted Therapies and Nutraceuticals

Dr. Abdel-Hadi emphasised the importance of integrating targeted therapies with natural compounds to enhance outcomes and minimise side effects. Examples included:

• Curcumin
  Targets cancer stem cells, inhibits metastasis, and optimises chemotherapy efficacy.

• Vitamin D
  Essential for immune modulation, with optimal levels (60-80 ng/mL) reducing cancer progression.

• Polyphenols (e.g., resveratrol, EGCG)
  Act as caloric restriction mimetics, supporting cellular repair and reducing tumour energy supply.

Exercise and Lifestyle: Enhancing the Body's Defence

Dr. Abdel-Hadi highlighted the role of exercise and lifestyle interventions in optimising the TME. Exercise stimulates immune activity, enhances circulation, and reduces systemic inflammation. However, regimens must be personalised to avoid overexertion in patients with bone metastases or advanced disease.

Examples of Personalised Exercise

• Swimming and Rebounding
  Low-impact activities that support lymphatic drainage and immune function.

• Blood Flow Restriction (BFR) Training
  An emerging modality for patients at risk of injury, enabling strength building without heavy loads.

Conclusion: A Holistic Vision for Cancer Care

Dr. Abdel-Hadi's session was a masterclass in integrative oncology, combining advanced science with compassionate patient care. Her insights into the tumour microenvironment, personalised interventions, and nutrigenomics demonstrate that effective cancer treatment extends beyond conventional methods.

By addressing the complexities of the TME, practitioners can empower patients with tailored strategies that optimise their body's natural defences while enhancing the efficacy of conventional therapies.

Key Takeaways

• The tumour microenvironment is both a challenge and an opportunity in cancer treatment.
• Personalised strategies, including nutrigenomics and gut microbiome optimisation, are essential.
• Integrating conventional therapies with targeted nutraceuticals and lifestyle interventions can improve outcomes.
• Empowering patients through holistic care transforms their journey from survival to thriving.

For more resources and tools, Dr. Abdel-Hadi recommended exploring the Recovery Fundamentals Programme and engaging with the latest research in integrative oncology.

Further Reading

For those interested in exploring Dr. Wafaa Abdel-Hadi's extensive work in functional medicine and integrative oncology, here are some recommended resources:

• Interview with Dr. Wafaa Abdel-Hadi
  In this interview, Dr. Abdel-Hadi shares her journey as the first certified Functional Medicine Doctor in Egypt and the Middle East, discussing her approach to integrative oncology and patient care.

• Revolutionising Cancer Care: Integrative Oncology and the Power of Personalized Medicine
  In this podcast episode, Dr. Abdel-Hadi discusses her transition from traditional cancer treatments to functional medicine, emphasizing the importance of personalized approaches incorporating genetics, nutrition, and lifestyle modifications.

• AWARE Clinic Functional Medicine
  Dr. Abdel-Hadi is the founder of AWARE Clinic, an online personalized applied metabolic therapy clinic established in 2014. The clinic focuses on educating individuals about functional medicine and integrative oncology.

• For more resources and information on Dr. Wafaa Abdel-Hadi's work, visit her professional website: https://drwafaafxmed.com/

For more resources and transcribed sessions from the Advanced Practitioner Conference, visit our Advanced Practitioner Conference page.

Get Access to the Full Conference Recording!

Submit the form below to unlock the complete video recording - don't miss out on insights from leading experts and thought leaders!

'

'